ALK-Abelló

ALK’s partner, MSD, publishes Phase II data on house dust mite SLIT-tablet in leading allergy journal journal

ALK announces top-line results from its partner MSD’s North American Phase III trial of house dust mite SLIT-tablet

Report on Management’s transactions with ALK-Abelló A/S B-shares and associated securities

CORRECTION: ALK to present at two upcoming 2015 Investor Conferences

ALK to present at two upcoming 2015 Investor Conferences

Three-month interim report (Q1) 2015

Release date of three-month interim report (Q1) 2015 for ALK

Report on Management’s transactions with ALK-Abelló A/S B shares and as-sociated securities

Grant of share options and conditional shares to members of the Board of Management and key employees

Annual general meeting of ALK-Abelló A/S held on 12 March 2015

Annual General Meeting in ALK-Abelló A/S on 12 March 2015

ALK and bioCSL enter into a partnership for allergy

ALK releases its annual report 2014

Release of annual report 2014 and audio cast

ALK’s partner, Torii, submits registration application for the house dust mite SLIT-tablet in Japan

ALK – Financial calendar for the 2015 financial year

Notification of ownership in ALK

ALK submits registration application for house dust mite SLIT-tablet in Europe

Nine-month interim report (Q3) 2014

ALK to present at Jefferies 2014 Global Healthcare Conference in London

Release date of nine-month interim report (Q3) 2014 for ALK

Report on Management’s transactions with ALK-Abelló A/S B-shares and associated securities

Report on Management’s transactions with ALK-Abelló A/S B-shares and associated securities

Grant of conditional shares to members of the Board of Management and key employees

ALK’s partner Torii initiates final stage of clinical development of Japanese cedar SLIT-tablet

ALK to participate at the Goldman Sachs European Biotech Symposium in London

ALK to present at the Morgan Stanley Global Healthcare Conference in New York

Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff

Six-month interim report (Q2) 2014

Release date of six-month interim report (Q2) 2014 for ALK